196 related articles for article (PubMed ID: 33899121)
1. Role of indoleamine 2,3-dioxygenase in ischemia-reperfusion injury of renal tubular epithelial cells.
Eleftheriadis T; Pissas G; Golfinopoulos S; Liakopoulos V; Stefanidis I
Mol Med Rep; 2021 Jun; 23(6):. PubMed ID: 33899121
[TBL] [Abstract][Full Text] [Related]
2. The Role of Indoleamine 2,3-Dioxygenase in Renal Tubular Epithelial Cells Senescence under Anoxia or Reoxygenation.
Eleftheriadis T; Pissas G; Filippidis G; Liakopoulos V; Stefanidis I
Biomolecules; 2021 Oct; 11(10):. PubMed ID: 34680153
[TBL] [Abstract][Full Text] [Related]
3. Reoxygenation induces reactive oxygen species production and ferroptosis in renal tubular epithelial cells by activating aryl hydrocarbon receptor.
Eleftheriadis T; Pissas G; Filippidis G; Liakopoulos V; Stefanidis I
Mol Med Rep; 2021 Jan; 23(1):. PubMed ID: 33179104
[TBL] [Abstract][Full Text] [Related]
4. Indoleamine 2,3-dioxygenase controls purinergic receptor-mediated ischemia-reperfusion injury in renal tubular epithelial cells.
Eleftheriadis T; Pissas G; Golfinopoulos S; Liakopoulos V; Stefanidis I
J Basic Clin Physiol Pharmacol; 2023 Nov; 34(6):745-754. PubMed ID: 35918786
[TBL] [Abstract][Full Text] [Related]
5. IDO decreases glycolysis and glutaminolysis by activating GCN2K, while it increases fatty acid oxidation by activating AhR, thus preserving CD4+ T‑cell survival and proliferation.
Eleftheriadis T; Pissas G; Liakopoulos V; Stefanidis I
Int J Mol Med; 2018 Jul; 42(1):557-568. PubMed ID: 29693118
[TBL] [Abstract][Full Text] [Related]
6. Proapoptotic activity of indoleamine 2,3-dioxygenase expressed in renal tubular epithelial cells.
Mohib K; Guan Q; Diao H; Du C; Jevnikar AM
Am J Physiol Renal Physiol; 2007 Sep; 293(3):F801-12. PubMed ID: 17609291
[TBL] [Abstract][Full Text] [Related]
7. Indoleamine 2, 3-dioxygenase 1 activation in macrophage exacerbates hepatic ischemia-reperfusion injury by triggering hepatocyte ferroptosis.
Ma S; Li J; Ye H; Wu C; Zhang J; Xu S; Song Y; Gu Y; Gao L
Int Immunopharmacol; 2024 Mar; 130():111692. PubMed ID: 38382261
[TBL] [Abstract][Full Text] [Related]
8. Kynurenine produced by indoleamine 2,3-dioxygenase 2 exacerbates acute liver injury by carbon tetrachloride in mice.
Hoshi M; Osawa Y; Nakamoto K; Morita N; Yamamoto Y; Ando T; Tashita C; Nabeshima T; Saito K
Toxicology; 2020 May; 438():152458. PubMed ID: 32289347
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of the aryl hydrocarbon receptor prevents Western diet-induced obesity. Model for AHR activation by kynurenine via oxidized-LDL, TLR2/4, TGFβ, and IDO1.
Moyer BJ; Rojas IY; Kerley-Hamilton JS; Hazlett HF; Nemani KV; Trask HW; West RJ; Lupien LE; Collins AJ; Ringelberg CS; Gimi B; Kinlaw WB; Tomlinson CR
Toxicol Appl Pharmacol; 2016 Jun; 300():13-24. PubMed ID: 27020609
[TBL] [Abstract][Full Text] [Related]
10. Indoleamine 2,3-dioxygenase depletes tryptophan, activates general control non-derepressible 2 kinase and down-regulates key enzymes involved in fatty acid synthesis in primary human CD4+ T cells.
Eleftheriadis T; Pissas G; Antoniadi G; Liakopoulos V; Stefanidis I
Immunology; 2015 Oct; 146(2):292-300. PubMed ID: 26147366
[TBL] [Abstract][Full Text] [Related]
11. Indoleamine 2,3-dioxygenase increases p53 levels in alloreactive human T cells, and both indoleamine 2,3-dioxygenase and p53 suppress glucose uptake, glycolysis and proliferation.
Eleftheriadis T; Pissas G; Antoniadi G; Spanoulis A; Liakopoulos V; Stefanidis I
Int Immunol; 2014 Dec; 26(12):673-84. PubMed ID: 25064493
[TBL] [Abstract][Full Text] [Related]
12. Mistimed H
Eleftheriadis T; Pissas G; Nikolaou E; Filippidis G; Liakopoulos V; Stefanidis I
Biomed Rep; 2020 Aug; 13(2):3. PubMed ID: 32509306
[TBL] [Abstract][Full Text] [Related]
13. Preconditioning of primary human renal proximal tubular epithelial cells without tryptophan increases survival under hypoxia by inducing autophagy.
Eleftheriadis T; Pissas G; Sounidaki M; Antoniadis N; Antoniadi G; Liakopoulos V; Stefanidis I
Int Urol Nephrol; 2017 Jul; 49(7):1297-1307. PubMed ID: 28417340
[TBL] [Abstract][Full Text] [Related]
14. Indoleamine 2,3-dioxygenase expression promotes renal ischemia-reperfusion injury.
Mohib K; Wang S; Guan Q; Mellor AL; Sun H; Du C; Jevnikar AM
Am J Physiol Renal Physiol; 2008 Jul; 295(1):F226-34. PubMed ID: 18480171
[TBL] [Abstract][Full Text] [Related]
15. Indoleamine 2,3-dioxygenase, by degrading L-tryptophan, enhances carnitine palmitoyltransferase I activity and fatty acid oxidation, and exerts fatty acid-dependent effects in human alloreactive CD4+ T-cells.
Eleftheriadis T; Pissas G; Sounidaki M; Tsogka K; Antoniadis N; Antoniadi G; Liakopoulos V; Stefanidis I
Int J Mol Med; 2016 Nov; 38(5):1605-1613. PubMed ID: 27667153
[TBL] [Abstract][Full Text] [Related]
16. The protective effect of 1-methyltryptophan isomers in renal ischemia-reperfusion injury is not exclusively dependent on indolamine 2,3-dioxygenase inhibition.
Čepcová D; Kema IP; Sandovici M; Deelman LE; Šišková K; Klimas J; Vavrinec P; Vavrincová-Yaghi D
Biomed Pharmacother; 2021 Mar; 135():111180. PubMed ID: 33433354
[TBL] [Abstract][Full Text] [Related]
17. Synergistic antitumor effect with indoleamine 2,3-dioxygenase inhibition and temozolomide in a murine glioma model.
Hanihara M; Kawataki T; Oh-Oka K; Mitsuka K; Nakao A; Kinouchi H
J Neurosurg; 2016 Jun; 124(6):1594-601. PubMed ID: 26636389
[TBL] [Abstract][Full Text] [Related]
18. Indoleamine 2, 3-dioxygenase Up-regulates Hypoxia-inducible Factor-1α Expression by Degrading L-tryptophan but Not Its Activity in Human Alloreactive T-cells.
Eleftheriadis T; Pissas G; Liakopoulos V; Stefanidis I
Iran J Allergy Asthma Immunol; 2018 Feb; 17(1):56-67. PubMed ID: 29512370
[TBL] [Abstract][Full Text] [Related]
19. The Opposite Effect of L-kynurenine and Ahr Inhibitor Ch223191 on Apoptotic Protein Expression in Pancreatic Carcinoma Cells (Panc-1).
Leja-Szpak A; Góralska M; Link-Lenczowski P; Czech U; Nawrot-Porąbka K; Bonior J; Jaworek J
Anticancer Agents Med Chem; 2019; 19(17):2079-2090. PubMed ID: 30987575
[TBL] [Abstract][Full Text] [Related]
20. Blockade of IDO-kynurenine-AhR metabolic circuitry abrogates IFN-γ-induced immunologic dormancy of tumor-repopulating cells.
Liu Y; Liang X; Yin X; Lv J; Tang K; Ma J; Ji T; Zhang H; Dong W; Jin X; Chen D; Li Y; Zhang S; Xie HQ; Zhao B; Zhao T; Lu J; Hu ZW; Cao X; Qin FX; Huang B
Nat Commun; 2017 May; 8():15207. PubMed ID: 28488695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
